ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 85 filers reported holding ACORDA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 40.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,602,000 | +29.2% | 3,110,567 | +84.4% | 0.00% | +100.0% |
| Q2 2020 | $1,240,000 | -20.9% | 1,687,215 | +0.4% | 0.00% | -50.0% |
| Q1 2020 | $1,567,000 | +1003.5% | 1,680,503 | +25224.0% | 0.00% | – |
| Q4 2017 | $142,000 | -78.3% | 6,636 | -56.5% | 0.00% | -100.0% |
| Q4 2015 | $653,000 | – | 15,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |